Psychological Effects/Therapist-Training MDMA Protocol Cleared by FDA The FDA permitted us to proceed with our clinical investigation, “A Phase I Placebo-Controlled, Double-Blind Crossover Study …
We submitted to FDA a protocol that would allow therapist from our MDMA/PTSD research teams to take MDMA in a clinical-therapeutic setting. We believe that it will benefit therapist who will be working …